Lung cancer breakthrough: chemo spares Low-Risk patients
NCT ID NCT07250360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved over 2,000 people with early-stage non-squamous lung cancer who had surgery. Researchers wanted to see if adding chemotherapy after surgery helped prevent the cancer from coming back. They found that chemotherapy only improved survival for patients with high-risk features, not for everyone. The team also created a computer tool to help doctors decide who should get chemo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE I are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.